PUREfi Wealth LLC Takes $211,000 Position in CME Group Inc. (NASDAQ:CME)

PUREfi Wealth LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 795 shares of the financial services provider’s stock, valued at approximately $211,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. New Age Alpha Advisors LLC increased its holdings in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares in the last quarter. Knuff & Co LLC bought a new stake in CME Group during the 4th quarter worth $33,000. Banque Transatlantique SA acquired a new position in CME Group in the 4th quarter worth about $35,000. Whipplewood Advisors LLC acquired a new position in CME Group in the 4th quarter worth about $37,000. Finally, United Community Bank bought a new position in CME Group in the fourth quarter valued at about $37,000. 87.75% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on CME shares. Oppenheimer boosted their price target on CME Group from $282.00 to $300.00 and gave the stock an “outperform” rating in a report on Wednesday, June 4th. Piper Sandler boosted their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a report on Tuesday, April 8th. Erste Group Bank downgraded shares of CME Group from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 24th. Bank of America lifted their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a report on Wednesday, April 2nd. Finally, Morgan Stanley boosted their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research note on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $258.20.

CME Group Stock Performance

Shares of CME opened at $269.70 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s fifty day simple moving average is $273.29 and its two-hundred day simple moving average is $254.82. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $290.79. The stock has a market capitalization of $97.19 billion, a P/E ratio of 27.13, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.50 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. As a group, analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Monday, June 9th. CME Group’s payout ratio is 50.30%.

Insiders Place Their Bets

In other news, Director Phyllis M. Lockett sold 1,060 shares of the business’s stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the sale, the director now owns 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Charles P. Carey sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director now directly owns 4,900 shares in the company, valued at $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,400 shares of company stock worth $3,680,610. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.